NASDAQ
Evelo Biosciences, Inc. (EVLO) has a fcf yield of -72.58% as of Friday, May 29, 2026. This represents a 137.20% decrease compared to its 12-month average of -30.60%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.